Novavax, Inc. (NVAX) Tops Q4 EPS by 7c
Tweet
Share
E-mailGet Alerts NVAX Hot Sheet
Price: $10.83 --0%
Financial Fact:
Interest expense: -3.51M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Financial Fact:
Interest expense: -3.51M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Novavax, Inc. (NASDAQ: NVAX) reported Q4 EPS of $0.03, $0.07 better than the analyst estimate of ($0.04). Revenue for the quarter came in at $5.85 million versus the consensus estimate of $6.87 million.
For earnings history and earnings-related data on Novavax, Inc. (NVAX) click here.
For earnings history and earnings-related data on Novavax, Inc. (NVAX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Royal Caribbean to acquire 50% stake in Sandals Resorts for $3 billion
- Goldman Sachs Downgrades Bank Mandiri (BMRI:IJ) (PPERF) to Sell, 'Liquidity and capital tightness'
- Oppenheimer Starts Teva Pharma (TEVA) at Outperform
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
